Results

Total Results: 1,855 records

Showing results for "summary".

261. Assessing Applicability (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/assessing-applicability.ppt
     January 01, 2009 - Using an applicability summary table for major questions may be helpful. Step 1. … Generate a summary applicability table with a PICOS structure. … A summary table with a PICOS structure should be generated. … of the summary table. … Summary Table for Body of Evidence Applicability In this slide, we use the template for a summary table

262. PKU Surveillance Assessment_CER 56_Low (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/phenylketonuria_surveillance.pdf
     January 15, 2013 - Summary Decision This CER’s priority for updating is Low AHRQ Comparative Effectiveness … ............................................................................ 21 Table Table 1: Summary … of date 2.5 Compilation of Findings and Conclusions For this assessment we constructed a summary … Table Conclusions From CER Executive Summary RAND Literature Search FDA/ Health Canada/MHRA (UK) … Conclusions From CER Executive Summary Is this conclusion almost certainly still supported by the

263. Treatments for Fecal Incontinence: A Review of the Research for Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/fecal-incontinence_consumer.pdf
     July 01, 2016 - The information in this summary is from research on adults. What will this summary tell me? … This summary will answer these questions: � What is FI? � What are treatment options for FI? … Note: This summary only discusses research on treatments for FI. … This summary was prepared by the John M. … People with fecal incontinence reviewed this summary.

264. Glaucoma-Screening Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-screening_surveillance.pdf
     January 01, 2013 - Summary Decision This CER’s priority for updating is Low AHRQ Comparative Effectiveness Review … ............................................................................ 43 Table Table 1: Summary … Table Conclusions From CER Executive Summary RAND Literature Search FDA/Health Canada/MHRA … Based on three glaucoma diagnosis 15 Conclusions From CER Executive Summary RAND Literature … The sensitivity and New Evidence: Conclusions From CER Executive Summary Is

265. Acs-Pci-Adjunctive-Devices Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/acs-pci-adjunctive-devices_surveillance.pdf
     April 01, 2013 - thrombectomy versus abciximab may be out of date; this was a small portion of one key question Summary … ............................................................................ 13 Table Table 1: Summary … of date 2.5 Compilation of Findings and Conclusions For this assessment we constructed a summary … Table Conclusions From CER Executive Summary RAND Literature Search FDA / Health Canada / MHRA … New Evidence: Conclusions From CER Executive Summary Is this conclusion almost

266. Disposition of Comments Report for Imaging Techniques for the Diagnosis and Staging of Hepatocellular Carcinoma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/liver-cancer_disposition-comments.pdf
     October 23, 2014 - Peer Reviewer #3 Executive Summary P 13 not all HCC is aggressive. … Peer Reviewer #6 Executive Summary ES8 - KQ1 section - a bit confusing. … in the Executive Summary. … The Strength of Evidence ratings are provided in the Summary of Evidence Table. … The first 36 pages are an executive summary and this should be shorter.

267. Disposition of Comments_Comparative Effectiveness Review No. 264_Social and Structural Determinants of Maternal Morbidy and Mortality: An Evidence Map (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-264-maternal-morbidity-mortality-disposition-comments.pdf
     December 21, 2023 - We have corrected the statistic to read as “49 percent” in the Evidence Summary Main Points. … The statistic was reported correctly in the Results section of the Evidence Summary and later in … We have corrected the statistic to read as “49 percent” in the Evidence Summary Main Points. … Final bullet in Main Points section of Executive Summary is not worded correctly. … We have corrected the statistic to read as “49 percent” in the Evidence Summary Main Points.

268. Disposition of Comments: Comparative Effectiveness Review No. 238 Cervical Ripening in the Outpatient Setting (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-238-cervical-ripening-outpatient-setting-comments.pdf
     March 22, 2021 - Jean Salera- Vieira, AWHONN Evidence Summary Well written summary. … Thank you for this summary. … Thank you for this summary. … Thank you for this summary. … Please see our report text for a narrative summary of this evidence.

269. Disposition of Comments_Systematic Review_Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: 2024 Update of the Evidence Base for the PTSD Trials Standardized Data Repository (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-pharm-non-pharm-treatment-update-disposition-comments.pdf
     August 28, 2024 - The key messages may be a bit less apparent – maybe bolding a summary statement in each section or … Peer Reviewer #2 Discussion and Conclusion In this section or in the Main Points/Exec Summary … TEP Reviewer #1 Executive Summary Suggest adding a statement/sentence in background and purpose … TEP Reviewer #1 Executive Summary On page 3, Introduction results section suggest adding a table … TEP Reviewer #1 Executive Summary I appreciate the limitation section on p 4 to address obvious

270. Disposition of Comments for Technical Brief 25 Disparities within Serious Mental Illness (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/mental-illness-disparities_disposition-comments.pdf
     May 26, 2016 - We have also summarized the key findings in the summary of findings section of the report. … We added a “summary of findings section” to address this in GQ4. … Peer Reviewer #3 Summary and Implications Very well written. Thank you. … We have also added a paragraph in the summary of findings section that states more clearly what are … Indians and Native Americans, these disparities groups might still be addressed in the summary and

271. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0007_03-17-2008.pdf
     January 01, 2008 - Topic Description Nominator: Health care professional association Nomination Summary: … There are more than a dozen Depression Treatment after SSRI Failure Nomination Summary Document

272. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0260_07-16-2010.pdf
     January 01, 2010 - Topic Description Nominator: Individual Nomination Summary: The nominator asks whether … Treatments for Tinnitus Nomination Summary Document http://effectivehealthcare.ahrq.gov/index.cfm/

273. Antibiotics-Respiratory-Infection Clinician (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/antibiotics-respiratory-infection_clinician.pdf
     March 01, 2016 - Improve Antibiotic Prescribing for Uncomplicated Acute Respiratory Tract Infections Focus of This Summary … This is a summary of a systematic review evaluating the evidence regarding the effectiveness and adverse … Although this summary provides a review of evidence, it should not be construed to represent clinical … For the purpose of this summary, acute RTIs include acute bronchitis, acute otitis media, pharyngitis … This summary was prepared by the John M.

274. Disposition of Comments Report for Technical Brief 15 Transition Care for Children With Special Health Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/children-special-needs-transition_disposition-comments.pdf
     June 17, 2014 - We agree and have addressed in the Summary and Implications section. … We address this issue in the “Summary and Implications” section. … We have addressed this issue in the revised “Summary and Implications” text. … Reviewer 7 (TEP) Summary & Implications The brief summary probably reflects the state of the science … Reviewer 7 (TEP) Summary & Implications The summary again fails to frame transition care as grounded

275. Psoriatic Arthritis Surveillance Assesment_CER 54_Low (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_surveillance.pdf
     March 01, 2013 - Summary Decision This CER’s priority for updating is Low AHRQ Comparative Effectiveness Review … ............................................................................ 22 Table Table 1: Summary … Summary RAND Literature Search FDA / Health Canada / MHRA (UK) Expert Opinion EPC Investigator … due to three new trials. 7 Conclusions From CER Executive Summary RAND Literature Search FDA … No pertinent evidence identified New Evidence: Conclusions From CER Executive Summary and

276. Community Forum Deliberative Methods Demonstration: Evaluating Effectiveness and Eliciting Public Views on Use of Evidence--Executive Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/deliberative-methods-demonstration-executive-131125.pdf
     November 01, 2013 - Methods Demonstration: Evaluating Effectiveness and Eliciting Public Views on Use of Evidence--Executive Summary … Demonstration: Evaluating Effectiveness and Eliciting Public Views on Use of Evidence Executive Summary … Demonstration: Evaluating Effectiveness and Eliciting Public Views on Use of Evidence Executive Summary … This executive summary and the associated final report were developed with ARRA funding, by the American … Executive Summary.

277. Omega-3 Fatty Acids and Cardiovascular Disease: A Review of the Research for Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/fatty-acids-cardiovascular-disease_consumer.pdf
     July 01, 2017 - This summary will tell you what researchers have found about omega-3 fatty acids and cardiovascular … blood pressure Do not lower blood pressure The Source of This Information The information in this summary … This summary was prepared by the John M. … Healthy adults, adults at risk for CV disease, and adults with CV disease gave feedback on this summary

278. Disposition of Comments_Systematic Review_Evaluation of Dietary Protein and Amino Acid Requirements: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-protein-intake-disposition-comments.pdf
     November 22, 2024 - https://doi.org/10.23970/AHRQEPCSRPROTEINAMINO https://effectivehealthcare.ahrq.gov/products Summary … In response, we moved the narrative summary and tables of all eligible studies to Appendix D and focused … However, this point does not align with the AHRQ Executive Summary Content Guidance, which emphasizes … #1 Methods, p 15 Please define “inconclusive” (used to describe strength of evidence in executive summary

279. Module III: Points of Engagement in the EHC Program (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/module-iii-points-of-engagement-in-the-ehc-program.pdf
     May 29, 2025 - Report Translation & Dissemination § Purpose § Test and provide input on summary … § Participate in focus groups § Participate in individual interviews § Provide expert review of summary … Stakeholder input is essential for the final translation of the research reviews and development of summary … Stakeholders may be involved with topic decision-context groups, summary guide reviews, and product … Slide 16 Summary of Module III § Identify and Involve stakeholders early in the process § There are

280. Intermittent Inhalded Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-194-evidence-summary-corticosteroids-asthma.pdf
     October 01, 2017 - Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma Executive Summary … Full Report This executive summary is part of the following document: Sobieraj DM, Baker WL, Weeda